ArticleClinical drug investigation2009

Effect on the atherogenic marker plasminogen activator inhibitor type-1 of addition of the ACE inhibitor imidapril to angiotensin II type 1 receptor antagonist therapy in hypertensive patients with abnormal glucose metabolism: a prospective cohort study in primary care.

Ken Yajima et al.PubMed ↗Publisher ↗

No numbers read from the abstract.